Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Tighe

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Experimental & Clinical Cancer Research : CR|October 17, 2021
Replication catastrophe is responsible for intrinsic PAR glycohydrolase inhibitor-sensitivity in patient-derived ovarian cancer modelsCamilla Coulson-Gilmer, Robert D Morgan, Louisa Nelson, et al.
Cancer Cell|July 16, 2015
MYC Is a Major Determinant of Mitotic Cell FateCaroline Topham, Anthony Tighe, Peter Ly, et al.
Disease Models & Mechanisms|September 27, 2021
TP53 loss initiates chromosomal instability in fallopian tube epithelial cellsDaniel Bronder, Anthony Tighe, Darawalee Wangsa, et al.
Cell Reports|October 18, 2018
The p38α Stress Kinase Suppresses Aneuploidy Tolerance by Inhibiting Hif-1αSusana Simões-Sousa, Samantha Littler, Sarah L Thompson, et al.
NAR Cancer|July 17, 2024
Intrinsic PARG inhibitor sensitivity is mimicked by <i>TIMELESS</i> haploinsufficiency and rescued by nucleoside supplementationCamilla Coulson-Gilmer, Samantha Littler, Bethany M Barnes, et al.
Cancer Cell|March 20, 2019
DNA Replication Vulnerabilities Render Ovarian Cancer Cells Sensitive to Poly(ADP-Ribose) Glycohydrolase InhibitorsNisha Pillay, Anthony Tighe, Louisa Nelson, et al.
Nature Communications|February 15, 2020
A living biobank of ovarian cancer ex vivo models reveals profound mitotic heterogeneityLouisa Nelson, Anthony Tighe, Anya Golder, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
A clinical-stage oncology compound selectively targets drug-resistant cancersKaitlin Long, Debanjan Bhattacharjee, Samuel H Newman-Stonebraker, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Experimental & Clinical Cancer Research : CR|October 17, 2021
Replication catastrophe is responsible for intrinsic PAR glycohydrolase inhibitor-sensitivity in patient-derived ovarian cancer modelsCamilla Coulson-Gilmer, Robert D Morgan, Louisa Nelson, et al.
Cancer Cell|July 16, 2015
MYC Is a Major Determinant of Mitotic Cell FateCaroline Topham, Anthony Tighe, Peter Ly, et al.
Disease Models & Mechanisms|September 27, 2021
TP53 loss initiates chromosomal instability in fallopian tube epithelial cellsDaniel Bronder, Anthony Tighe, Darawalee Wangsa, et al.
Cell Reports|October 18, 2018
The p38α Stress Kinase Suppresses Aneuploidy Tolerance by Inhibiting Hif-1αSusana Simões-Sousa, Samantha Littler, Sarah L Thompson, et al.
NAR Cancer|July 17, 2024
Intrinsic PARG inhibitor sensitivity is mimicked by <i>TIMELESS</i> haploinsufficiency and rescued by nucleoside supplementationCamilla Coulson-Gilmer, Samantha Littler, Bethany M Barnes, et al.
Cancer Cell|March 20, 2019
DNA Replication Vulnerabilities Render Ovarian Cancer Cells Sensitive to Poly(ADP-Ribose) Glycohydrolase InhibitorsNisha Pillay, Anthony Tighe, Louisa Nelson, et al.
Nature Communications|February 15, 2020
A living biobank of ovarian cancer ex vivo models reveals profound mitotic heterogeneityLouisa Nelson, Anthony Tighe, Anya Golder, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
A clinical-stage oncology compound selectively targets drug-resistant cancersKaitlin Long, Debanjan Bhattacharjee, Samuel H Newman-Stonebraker, et al.
Pageof 3